Pelthos Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-6.4M | $100.0K |
| FY2024 | — | $-2.7M | $513.0K |
| FY2025 | — | $38.9M | $18.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-6.4M | $100.0K |
| FY2024 | — | $-2.7M | $513.0K |
| FY2025 | — | $38.9M | $18.0M |